Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
230.00    9.00 (4.07%)
Bid:
229.00
Ask:
230.00
Spread: 1.00 (0.437%)
Market Cap: £134.17m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Covid-19 Update

25 Mar 2020 15:38

RNS Number : 6071H
MJ Gleeson PLC
25 March 2020
Β 

MJ Gleeson plc (GLE.L)

("Gleeson" or "the Company")

Β 

For immediate release

25 March 2020

Covid-19 Update

Corporate Actions

Β 

Β 

The Board of MJ Gleeson plc has been closely monitoring and assessing the impact on the business of the rapidly evolving COVID-19 pandemic.

Covid-19 and Corporate Actions

First and foremost, our priority must be to protect the health, safety and wellbeing of our colleagues, customers and the wider communities where we operate.

Following recent guidance from the Government, we have taken the decision that all sites will cease build activity and that we will temporarily close our development sites in the coming days. We will continue to support our customers and prospective customers online and by phone.

We have decided that a controlled wind down and closure of site activity on a temporary basis is the right thing to do at this time. It supports the Government's key message of "Staying at Home, Protecting the NHS and Saving Lives": we all have an obligation to do this where we can.Β 

We will continually review the situation, taking action where necessary, and we will look to reopen sites and sales offices once it is appropriate and safe to do so.

Gleeson builds and sells low-cost quality 2, 3 and 4 bedroom homes to first time buyers on average and lower incomes across the Midlands and North of England, areas where there are already acute supply shortages. We recognise that the current situation will further exacerbate this position and we will look to work with central government and local authorities to ascertain what provisions might be put in place to see the safe resumption of building of much-needed quality affordable homes as soon as possible.

It should be noted that a significant proportion of the homes we sell are to people in what are now designated "key worker" roles. The Board has decided that when we are able to recommence selling, we will look to prioritise sales to front-line and other key workers in recognition of the extraordinary role that they are playing at this time.

Trading and Financial Update

In light of the uncertainties the Company currently faces, it is unable to provide guidance on the full year results to 30 June 2020.

As a result of a disciplined approach to cash management and capital allocation, the Company has a strong balance sheet. This is reflected in cash balances of Β£67m, including Β£60m drawn down from the Company's committed bank facility, in addition to a Β£10m committed overdraft facility. The Board believes that the Company is in a resilient position.

Β 

Given the ongoing uncertainty around the duration and potential impact of Covid-19, however, the Board believes it would also be prudent to cancel the payment of the interim dividend of 12.0 pence per share due to be paid on 3 April 2020 to shareholders on the register at close of business on 6 March 2020.Β The interim dividend equates to Β£6.6m.

Dermot Gleeson, Chairman, commented:

"The decisions we are announcing today have not been taken lightly but I believe that all our stakeholders will agree that we need to take these steps in what are extraordinary and uncertain times. We will not hesitate to implement additional measures if we judge that they are necessary to ensure the safety and wellbeing of our colleagues and the wider community. We are also determined to ensure that the Company remains well placed to return to the task of delivering homes to people who need them just as soon as circumstances permit."Β 

ENDS

Enquiries:

Instinctif Partners

Tel: +44 7771 860938

Mark Garraway

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDUVOVRRUUOUAR
Date   Source Headline
30th Mar 20204:13 pmRNSCompany Secretary Change
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
25th Mar 20203:38 pmRNSCovid-19 Update
23rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202012:08 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
9th Mar 20209:49 amRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSTotal Voting Rights
13th Feb 202012:02 pmRNSPrice Monitoring Extension
13th Feb 20207:00 amRNSHalf-year Report
10th Feb 20202:32 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSTotal Voting Rights
9th Jan 20207:00 amRNSNotice of Results and Trading Update
8th Jan 20206:05 pmRNSDirector/PDMR Shareholding
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20196:09 pmRNSExercise of options, PDMR Dealing and TVR
19th Dec 201912:07 pmRNSSecond Price Monitoring Extn
19th Dec 201912:02 pmRNSPrice Monitoring Extension
18th Dec 201910:15 amRNSDirector/PDMR Shareholding
11th Dec 20195:22 pmRNSPerformance Share Plan award to Directors/PDMRs
9th Dec 201911:31 amRNSDirector/PDMR Shareholding
5th Dec 20193:18 pmRNSResult of AGM
5th Dec 20197:00 amRNSAGM Statement
3rd Dec 20194:07 pmRNSTotal Voting Rights
2nd Dec 20197:01 amRNSIncentive Plan Share Issue
2nd Dec 20197:00 amRNSAppointment of Chief Executive Officer
29th Nov 20197:00 amRNSTotal Voting Rights
12th Nov 20193:40 pmRNSPerformance Share Plan award to Directors/PDMRs
11th Nov 201910:12 amRNSDirector/PDMR Shareholding
4th Nov 20197:00 amRNSNotice of AGM
31st Oct 201912:13 pmRNSRe Committee Appointments
31st Oct 20197:00 amRNSTotal Voting Rights
16th Oct 20193:58 pmRNSHolding(s) in Company
9th Oct 201912:05 pmRNSDirector/PDMR Shareholding
9th Oct 201911:46 amRNSDirector/PDMR Shareholding
8th Oct 20192:09 pmRNSExercise of Options and Total Voting Rights
30th Sep 20197:00 amRNSTotal Voting Rights
24th Sep 20197:00 amRNSAppointment of Non-Executive Directors
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
16th Sep 20197:00 amRNSFinal Results
10th Sep 20195:35 pmRNSDirector/PDMR Shareholding
30th Aug 20197:00 amRNSTotal Voting Rights
14th Aug 20194:35 pmRNSPrice Monitoring Extension
8th Aug 20199:32 amRNSDirector/PDMR Shareholding
7th Aug 20191:40 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 201910:55 amRNSDirector/PDMR Shareholding
4th Jul 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.